Med-Sci 2009

A Celebration of ASAM’s Membersand Their AchievementsMichael M. Miller, M.D., FAPA, FASAMOutgoing ASAM President

Welcome to Med-Sci! I’d like to congratulate all of ASAM’s honorees atthis 40th annual conference, including Drs. Nora Volkow and LarryBrown, the other award winners, the recipients of ASAM Certificates,

and the recipients of ABAM Diplomas.Indeed, many thanks are in order. The ASAM staff is incredibly dedicated,

and specifically supported my activities as President and Board Chair. Similarly,none of ASAM’s successes could have happened without the volunteer

contributions of our Board of Directors. I’ve never seen an ASAM Board as good as this one. The engagementin the discussions, the thoughtful analysis before making important decisions, the participation in all theconference calls and traveling at their own expense — that’s right, with no reimbursement for travel — toASAM Board meetings: I couldn’t have had a better experience with the governing Board than I’ve had.And thanks to our tireless CEO, Eileen McGrath, who guides the Board and provides all of us with informa-tion to consider as they make the decisions vital to ASAM’s present and future.

I also must thank my partners back home at Meriter Hospital’s NewStart Program. I just celebrated 20years as Medical Director of NewStart, but I couldn’t meet the clinical needs there without other physicianswho have been wonderful colleagues over those 20 years, beginning with Roy Yeazel and Fritz Koeneke,

InsideMed-SciCoverage:

Report from the EVP / 2

ADM News / 3

From thePresident-Elect / 5

Med-Sci Highlights / 6

Daily Planner / 8

New Fellows of ASAM / 10

Non-PhysicianMembers? / 12

Ruth Fox Fund / 14

In Memoriam / 15

Calendar of Events / 16

Should ASAM openits membership tonon-physicians?For two points ofview, see page 12.

WWW.ASAM.ORG

A Commitment to Meet ASAM’sFuture ChallengesLouis E. Baxter, Sr., M.D., FASAMIncoming ASAM President

T he challengesthat lie aheadfor our ASAM

organization are numer-ous and quite formi-dable, not unlike thosechallenges that are

facing our Nation. Even in the wake of ASAM’shistoric and monumental accomplishments ofsuccessfully supporting the enactment of paritylegislation and establishing the American Board ofAddiction Medicine (ABAM), our work has just begun.

These accomplishments were made possible onlyby the efforts of so many of our determined andtalented ASAM members. The work that lies aheadwill require continued extraordinary effort on thepart of our members — those addiction expertswho’ve made parity and ABAM a reality. The

Med-Sci 2009 Volume 24, Number 2

challenges that lie ahead — some known, others asyet unknown — may be difficult, but they are notinsurmountable for us as a specialty society.

For example, ASAM must closely monitor theimplementation of the parity legislation to ensurethat it provides meaningful access to the patientswho rely on our care, and affords a full range ofnecessary treatment services.

ASAM also needs to continue to focus on affirmingits role the resource for state-of-the art addictionmedicine education, as well as evidence-based treat-ment recommendations and related guidelines. Thismust include a special focus on medical student andresident education, while also providing continuingmedical education to our Board-certified and Board-eligible practicing addiction medicine specialists.

ASAM also must focus on developing educational

WELCOME TO MED-SCI!

continued on page 4

Louis E. Baxter, Sr.,M.D., FASAM

continued on page 4

Michael M. Miller, M.D.,FAPA, FASAM

2 ASAMNews / Vol. 24, No. 2

REPORT FROM THE EVP

American Society ofAddiction Medicine

4601 North Park Ave., Suite 101Chevy Chase, MD 20815

ASAM is a specialty society of physiciansconcerned about alcoholism and otheraddictions and who care for persons

affected by those illnesses.

OfficersPresident

Michael M. Miller, M.D., FASAM, FAPA

Immediate Past PresidentElizabeth F. Howell, M.D., FASAM

President-ElectLouis E. Baxter, Sr., M.D., FASAM

SecretaryA. Kenison Roy III, M.D., FASAM

TreasurerStuart Gitlow, M.D., M.P.H., M.B.A.

Executive Vice President/CEOEileen McGrath, J.D.

ASAM NEWSis an official publication of the

American Society of Addiction Medicine.It is published six times a year.

Please direct all inquiries tothe Editor at [email protected]

or phone 410/770-4866.

Chair, Publications CouncilElizabeth F. Howell, M.D., FASAM

Newsletter Review BoardLeClair Bissell, M.D.

Sheila B. Blume, M.D., FASAMMax A. Schneider, M.D., FASAM

Founding Editor, 1985-1995Lucy Barry Robe

EditorBonnie B. Wilford

SubscriptionsFree to ASAM members; $99 a year

(six issues) to nonmembers.To order, phone 1-800/844-8948

or fax 301/206-9789.

AdvertisingAdvertising rates and schedules

are available on request.Please direct inquiries to

the Editor at 410/770-4866or email [email protected].

Web SiteFor more news visit ASAM’s

web site at WWW.ASAM.ORG.

ASAM Honors Achievements inScience, Education and Policy

Eileen McGrath, J.D.Executive Vice President/CEO

Eileen McGrath, J.D.

A t this year’s Medical-Scientific Conference, ASAM willhonor a distinguished group of individuals who havemade outstanding contributions to the field of

Addiction Medicine and to the Society itself. The awardeeswill be honored at a gala Awards Luncheon on Saturday,May 2nd. Our 2009 awards will be presented to the follow-ing outstanding leaders.

The John P. McGovern Award on Addiction and Societygoes to Congressman Patrick Kennedy for his seminal con-tribution to the enactment of federal parity legislation. TheMcGovern Award was established in 1997 to recognize andhonor an individual who has made “highly meritoriouscontributions to public policy, treatment, research, orprevention, which has increased our understanding of therelationship of addiction and society.” The award is sponsoredby an endowment from the John P. McGovern Foundation.

The 2009 R. Brinkley Smithers Distinguished ScientistAward goes to our own Marc Galanter, M.D., FASAM, Director of the Division of Alcoholismand Drug Abuse at New York University School of Medicine and a Past President of ASAM.The award will be presented at the Opening Plenary Session at 9:00 a.m. Friday, May 1st. Atthat time, Dr. Galanter will deliver the award lecture, “Spirituality, Social Affiliation, andAlcoholics Anonymous: Broadening the Base of Empirical Medicine.”

The ASAM Annual Award for “outstanding contributions to the growth and vitality of ourSociety, for thoughtful leadership in the field, and for deep understanding of the art andscience of addiction medicine” will be presented to Lawrence S. Brown, Jr., M.D., M.P.H., FASAM.

An ASAM Annual Award for “expanding the frontiers of the field of Addiction Medicineand broadening our understanding of the addiction process through research and innova-tion” will be presented to Nora D. Volkow, M.D., for her multiple contributions as a researcher,educator, and Director of the National Institute on Drug Abuse.

The Young Investigator Award for the best abstract submitted by an author who is withinfive years of receiving a doctoral degree goes to Philip P. Lobmaier, M.D.

The Medical-Scientific Program Committee Award for the abstract receiving the highestrating for scientific merit goes to Walter Ling, M.D.

The Awards Luncheon is an extra-fee event. Visit the ASAM Registration Desk for tickets (at$55 each) so that you can join us in recognizing the achievements of this distinguished group.

AMERICAN BOARD OFADDICTION MEDICINE

Inaugural Diplomates’ LuncheonSaturday, May 2, 2009

Hilton New Orleans Riverside HotelNew Orleans, Louisiana

Honoring 1,281 new Diplomates of the American Board of Addiction Medicine.Special guest: Nora D. Volkow, M.D., Director, National Institute on Drug Abuse

Med-Sci 2009 3

ADM NEWS

President Barack Obama has announced hisintention to nominate A. Thomas McLellan,Ph.D., to the post of Deputy Director of theWhite House Office of National Drug ControlPolicy (ONDCP). Dr. McLellan is Professor ofPsychology in Psychiatry at the University ofPennsylvania and Chief Executive Officer ofthe Treatment Research Institute (TRI), a not-for-profit research and development institute.

If confirmed by the Senate, Dr. McLellanwill lead the Office of Demand Reductionwithin ONDCP. In March, President Obamanominated Seattle Police Chief Gil Kerli-kowske to head ONDCP. Chief Kerlikowske’sreputation for innovative approaches to lawenforcement and Dr. McLellan’s stature as atreatment expert make them “a perfectmatch,” said Steve Pasierb, president and CEOof the Partnership for a Drug-Free America.

Dr. McLellan is nationally and internation-ally recognized for his 30+ years of researchinto treatment effectiveness. As a scientistat the Veterans Administration MedicalCenter in Philadelphia in the 1980s, hedeveloped two instruments, the AddictionSeverity Index (ASI) and the TreatmentServices Review (TSR) — measurement instru-ments that characterize the multiple dimen-sions of problems confronting substanceabusing patients and the types and durationof treatment services offered in response.Now translated into more than 20 languages,the ASI and TSR are the most widely usedinstruments of their kind in the world.

In 1991, Dr. McLellan co-founded TRI totranslate the results of research to policy-makers, addiction treatment professionals,prevention organizations, and the familiesof individuals affected by addiction. Help-ing primary care physicians recognize andrespond to symptoms of alcohol and druguse in their patients is a major thrust of TRI’swork, as is its emphasis on removing bureau-cratic impediments to high-quality treatmentand translating evidence-based practices forpopulations such as substance-using offenders.Through TRI and other endeavors, Dr. McLellanhas promoted better understanding of thefactors that lead to treatment success andfostered better understanding of addictionas a chronic illness that must be continuallymonitored and managed in the same manner

A long-simmering controversy within the addiction researchcommunity was reignited in February when a special review boardpublicly raised the issue of merging the National Institute on DrugAbuse (NIDA) and the National Institute on Alcohol Abuse andAlcoholism (NIAAA).

When the National Institutes of Health (NIH) were reauthorizedby Congress in 2006, a Scientific Review Management Board (SRMB)was created to report on the way NIH was organized. The NIDA-NIAAA merger is one of two inaugural SRMB recommendations(the other involves the NIH Intramural Research Program).

The main argument in favor of merger is that efficiencies canbe attained by joining the two addiction-focused institutes. Intheory, a single agency would yield lower overhead costs and aleaner bureaucracy. Ideally, savings would be realized not onlyby eliminating redundancies within the two institutes, but forNIH as a whole.

This is not the first time such a suggestion has been made. Amerger was considered most recently in 2003 at the request ofthe National Academy of Sciences. Former NIAAA Director Enoch

Dr. McLellan Named Deputy Director of ONDCP

Gordis, M.D., was one of the most vocal opponents of that merger.He argued that alcohol-focused research was already receivingonly a fraction of the funding that it deserved, and there was noway a merger would improve that situation. To the contrary, hesaid, a merger risked overshadowing alcohol as it became subsumedby NIDA’s pre-existing agenda and objectives. (NIDA’s fiscal year2009 budget was $1,032,700,000, while NIAAA’s was less thanhalf that amount at $450,200,000).

One ironic effect of a merger would be a renewed chance tore-name the institutes — a push that was made during Congress’slast session but ultimately fell short. A bill supported by NIDAand NIAAA themselves would have re-named NIDA the NationalInstitute on Diseases of Addiction and NIAAA the NationalInstitute on Alcohol Disorders and Health.

No merger is imminent, as the number of bureaucratic stepsthat must be taken before any merger could be realized is daunt-ing. Some field organizations, such as the National Associationof Addiction Treatment Providers (NAATP), are opposing themerger proposal. ASAM has not taken a position on the matter.

MERGER OF NIAAA, NIDA PROPOSED

as other chronic medical conditions such asdiabetes and hypertension.

The author of more than 400 articles andtextbook chapters on addiction, Dr. McLellanis Editor-in-Chief of the Journal of SubstanceAbuse Treatment. He also is an advisor to manygovernment and nonprofit scientific organi-zations. Among his many honors are awardsfrom ASAM and from the Swedish MedicalAssociation, the British Medical Association,and the Robert Wood Johnson Foundation.

Addiction field leaders were unanimous intheir praise for the appointment. FormerWhite House Drug Policy Director Robert L.DuPont, M.D., who also was first director ofthe National Institute on Drug Abuse (NIDA)and is now President of the Institute forBehavior and Health, said: “The nominationof Tom McLellan, Ph.D., to be Deputy Direc-tor of ONDCP is the most important WhiteHouse appointment for substance abusetreatment in over a decade. Tom is widelyrecognized as the leading drug treatmentresearcher in the world. He has no peers andno detractors. He enjoys a unique positionof respect from this field that seldom agreeson anything. Dr. McLellan is the man and thisis the hour to revitalize drug abuse treat-ment and to raise the national priority fordemand reduction. This appointment bringsgreat credit to the Obama Administration.It fulfills the President’s ambition to bringnew ideas to solve long-neglected, urgentnational priorities.”

A. Thomas McLellan, Ph.D.


FROM THE PRESIDENTS

A CELEBRATION OF ASAM’S MEMBERS AND THEIR ACHIEVEMENTS continued from page 1

and then a number of ASAM memberswhom you know — David Hendricks, IanPowell, Randy Brown, Aleksandra Zgierska,Basil Spyropoulos, and Michael Witkovsky.These last six who have covered call while Ihave been away on ASAM, AMA and otheractivities — two internists, two familyphysicians and two psychiatrists — havecomprised a wonderful team to meetpatients’ needs the way the ABAM mottosays it — “with skill, with knowledge, withcompassion.”

My thanks also go to ASAM members fromevery state and every Chapter, who work sofaithfully for their patients, and so many ofwhom work so faithfully for ASAM. Appre-ciation also to the ASAM-certified physicianswho not only sought a credential for them-selves but also understood that they werecontributing to the future of AddictionMedicine through their decision to gothrough the application process to become“grandfathered” into the status of Diplomateof the American Board of Addiction Medicine.And thanks to Dr. James Callahan, newlynamed head of ABAM.

The biggest thanks, of course, go to mywife Kathy. Virtually none of you know her— she doesn’t come to professional meetingswith me. She has clearly been “widowed”these past four years. She has put it differ-ently — she said it was as if I had a girlfriend.That’s a sad but realistic commentary on how

I’ve been married to ASAM and ABAM overthe past four years — and I promise you, I’mlooking forward to getting back to my truelove and my real home. Every day or hoursomeone spends on the activities of “orga-nized medicine” is a day or hour that is notspent with the family. Kathy is fully aware ofwhat parity means, and what ABAM means,and what the achievements of ASAM willmean to patients and their doctors for yearsto come. She is truly the “silent champion”of whatever my efforts have been able tocontribute to ASAM’s successes.

So yes, my professional life is very importantto me, but my family is even more impor-tant. Kathy has been a wonderful motherto our children for more than 29 years now.Space doesn’t permit me to gush and gloatas a parent about Courtney and her sisterAnnie, a University of Michigan graduatefrom 2002, but my closest friends in ASAMknow how proud Kathy and I are of ourdaughters.

I’m quite proud as well of what’s happenedto ASAM during my Presidency. During mytenure, ASAM has focused on “the Big Two”— the establishment of an American Boardof Addiction Medicine to increase recogni-tion of our field, and enactment of federalparity legislation to provide better access totreatment for our patients. ASAM hasaccomplished many things in the past twoyears, but when you look at the Big Two,

A COMMITMENT TO MEET ASAM’S FUTURE CHALLENGES continued from page 1

programs and other resources for our colleagues in other specialtieswho collaborate in caring for many of our patients. Moreover, ASAMis invested in emphasizing the value of early recognition andprevention of addiction, as evidenced by our Society’s support forScreening, Brief Intervention, and Referral to Treatment (SBIRT) andthe practice of Adolescent Medicine, respectively.

ASAM will continue to pursue and publicize advances in the basicsciences and clinical research by nurturing our close relationshipswith Governmental and non-Governmental agencies that supportand conduct research and demonstration projects (e.g., CSAT,NIAAA, NIDA), education (AMERSA, AAAP, AOAAM, and othermedical specialty societies), and evaluations of treatment outcomes(ONDCP, HRSA, SAMHSA, and the VA).

There will be many opportunities for interested ASAM membersto be involved in these and other efforts. In fact, there is a role inASAM for every willing member.

Finally, I believe it is essential that ASAM continues to supportadvocacy, not only for our patients, but also for our colleaguephysicians and other allied health professionals during their own

personal journeys in recovery. Addiction is an equal opportunitydisease and has affected many of those within and outside ouraddiction treatment workforce. As ASAM seeks to expand thenumber of providers in our workforce, it also needs to advocate forprevention while at the same time working for the reintegration ofour fellow health care professionals who have fallen ill but are nowin recovery and who are willing to cooperate with any ongoingmonitoring that their continued wellness may require.

As President of ASAM, I pledge to represent and serve you andyour highest aspirations as caregivers. I cannot do this alone. I willcontinue to call upon you, confident that you will continue to lendus the rich talent and expertise that characterizes our membership.Only in this way can we, together, redefine and further develop thisunique organization called ASAM, in its evolving role as a well-recognized, well-established, and increasingly respected professionalspecialty society. I especially look forward to representing ASAM incooperating with our newly formed and closely related specialtyBoard, the American Board of Addiction Medicine.

Thank you for this opportunity to serve.

has ASAM ever delivered! The evidence isin our midst, with Dr. Nora Volkow handingout Diplomate certificates from a new inde-pendent Certification Board, and Represen-tative Patrick Kennedy being honored forco-authoring mental health and addictionparity legislation that is now the law of theland. These accomplishments are rewardsthat all of us can share!

I’m pleased to say that we’ve also attendedto ASAM’s strength as an organization. Atthe time I was elected, ASAM had $400,000in its reserve fund and $4,000,000 in itsendowment fund. The former dropped tozero, and the stock market helped bring thelatter down by half. But through the estab-lishment of ABAM and its GrandfatheringProgram, the reserve fund stands to reach$500,000 if the grandfathering offer fromABAM continues to prove attractive toASAM-certified physicians.

Finally, thanks to two other ASAM Presi-dents. ASAM has a tradition of the currentPresident leading as part of a triumviratewith the Immediate Past President and thePresident-Elect. In Drs. Elizabeth Howell andLouis Baxter, I couldn’t have had better col-leagues: supportive and wise, well-temperedand dedicated. I congratulate Beth Howellon her retirement from the ASAM Board,and salute Lou Baxter on the beginning ofwhat will be two great years — ASAM is inwonderful hands with this gifted leader.

Med-Sci 2009 5

FROM THE PRESIDENT-ELECT

Donald J. Kurth, M.D., M.B.A.,M.P.A., FASAM

Addiction Public Policy Goals For the Next CenturyDonald J. Kurth, M.D., M.B.A., M.P.A., FASAM

ASAM President-Elect

CONGRATULATIONS! Congratulationsto all of you who care about thosesuffering from addictive disease! Con-

gratulations to all who have worked these manyyears to change the course of our Nation towarda more sensible public policy regarding addic-tion treatment. The signing into law of themental health parity act by President GeorgeW. Bush on October 3, 2008, brought the rightto treatment to all those Americans covered byprivate insurance and Medicare who suffer fromthis ageless malady. But the work is not doneyet, even at the most basic level. We still haveto be sure that the implementation regulationsare written in a way that actually manifests thespirit of the law — that is, access to treatmentfor addiction — but the framework has beencreated and it is up to us to continue to build onthat structure.

We have achieved our goal; parity is ours, what more needs to bedone? As far as we have come, we still have a long, long way to go.Let me give you two obvious suggestions for public policy goals forthe addiction field. Our first goal must be to end the national,institutionalized discrimination against all those who suffer, or whohave ever suffered, from addiction to alcohol or other drugs. I spokerecently to a group of adolescents in the Daytop Village treatmentcenter in New York City and answered questions at the end of mytalk. One of their major concerns — perhaps their greatest concern— was how they would ever get into college or get a job if theywere honest about their drug addiction and treatment. This is asad state of affairs. These were teenagers, mind you. Instead offocusing on getting well and getting on with their lives, they areworrying about how they will overcome the stigma and discrimina-tion that they know is waiting for them down the road.

I recently attended a talk on discrimination in the workplace.During the talk I realized that, along with race, gender, nationalorigin, and other protected classes of people, some areas of Cali-fornia law include “medical condition” as a protected class ofindividuals. Yet, for the most part, federal law offers no suchprotection. Think about this: Should somebody who has had a cancerexcised, or even is in long term remission, be refused employmentbecause of their medical condition? Should someone who hassuffered a myocardial incident, and who is now healthy and active,be passed over for advancement based on their medical history?Similarly, should an alcoholic or addict who is clean and sober foryears or decades have to continue to answer the question, “Haveyou ever been treated for drug or alcohol dependence?” These areegregious examples of institutionalized discrimination perpetuatedagainst recovered and recovering people every day. And we haveto put a stop to this sort of stigma if we ever hope to help ourpatients fully recover and fully reintegrate into society.

Our second goal should be to provide unfet-tered access to treatment on request for everyAmerican suffering from addiction. Those whounderstand the chronicity of this disease andthe concomitant denial so often present, under-stand that over the years- or even decades-long course of the disease, the windows ofduring which individuals are receptive to treat-ment may open only for a few weeks, days, oreven hours. If we are ever to bring this diseaseto its knees, we must address addiction at thelevel of a public health malady.

Think about this. If we wanted to preventthe spread of tuberculus bacilli or syphilitictreponemes, we would not make thosesuffering from those disorders beg, scrape, ordemand treatment. To the contrary, we wouldwelcome them into treatment. We would make

treatment easily accessible whenever and wherever they wanted it.At the very least, we would want to make treatment readily avail-able so that infected patients do not continue to spread their diseasesto others. And so our public health policies encourage people withthese sorts of communicable diseases to access treatment.

Similarly, with alcohol and other drug addiction — particularlyamong our youth — we should want to stop the spread of thisdisease. We should not want sufferers to continue to have peerpressure or adult role models of socially accepted addiction andalcoholism on television, in their communities, or in their homes.The only way to accomplish this, however, is to provide a nationwidepublic health environment in which every American, even at theearliest stages of addiction, is welcomed into treatment wheneverit is needed.

In July 2008, then-Senator Barack Obama said, “Anybody whosees the devastating impact of the drug trade in the inner cities, orthe methamphetamine trade in rural communities, knows that thisis a huge problem. I believe in shifting the paradigm, shifting themodel, so that we focus more on a public-health approach.” OurPresident is right. This disease has to be addressed on a public healthlevel. ASAM’s role must be to educate our policymakers and leadthe way for our Nation. Come join us in changing the world for allthose who suffer from this lethal disease. Write your Congressman;write your Senator; and come join us at the next ASAM AddictionTreatment Legislative Day. The world is ours to change if we arewilling to get involved.

DONALD J. KURTH, MD, MBA, MPA, FASAM is President Elect of theAmerican Society of Addiction Medicine and Mayor of the City of RanchoCucamonga, California. He is the founder of both the California and theNational Annual Addiction Treatment Legislative Days and a past recipientof the prestigious Robert Wood Johnson Foundation Fellowship for Devel-oping Leadership in Reducing Substance Abuse. You can learn more abouthis work at WWW.DONKURTH.COM.


MED-SCI CONFERENCE

The Hilton New Orleans Riverside Hotelwelcomes you to ASAM’s 40th AnnualMedical-Scientific Conference, where

addiction experts from around the worldgather for a program rich in scientific sym-posia, clinical courses and workshops, andresearch papers and poster sessions.

The conference welcomes ASAM membersas well as non-member researchers, educa-tors, and clinicians. It is preceded on April30th by the Ruth Fox Course for Physiciansand the annual course on “Pain and Addic-tion — Common Threads,” which focusesthis year on “Lessons from Katrina.”

BUSINESS MEETING. The Annual BusinessMeeting and Breakfast will be gaveled toorder Friday, May 1st, at 7:30 a.m. by ASAMPresident Michael M. Miller, M.D., FASAM,FAPA. Early risers will be rewarded with abuffet breakfast, to be served from 7:15a.m., courtesy of The Christopher D. SmithersFoundation. The business meeting affordsan opportunity for members to offer theirviews on ASAM’s needs and priorities. It alsomarks the official installation of Dr. Louis E.Baxter, Sr., as ASAM’s President, Dr. DonaldJ. Kurth as President-Elect, Dr. C. ChapmanSledge as Secretary, Dr. Stuart Gitlow asTreasurer, and new members of ASAM’sBoard of Directors.

OPENING SESSION. The official openingsession of the Conference at 9:00 a.m. Fridayfeatures an address by Marc Galanter, M.D.,

WELCOME TO ASAM’S 40TH ANNUALMED-SCI CONFERENCE!

FASAM, Director of the Division of Alcoholismand Drug Abuse at the New York UniversitySchool of Medicine, who is the 2009 recipientof the R. Brinkley Smithers DistinguishedScientist Award. Dr. Galanter will deliver theaward lecture on “Spirituality, Social Affilia-tion, and Alcoholics Anonymous: Broaden-ing the Base of Empirical Medicine.” Otherdistinguished speakers invited to addressthe opening plenary are Nora D. Volkow,M.D., Director of the National Institute onDrug Abuse, and Congresswoman MaryBono Mack.

PUBLIC POLICY PLENARY. On Saturday,the day begins with a Public Policy plenarysession at 8:00 a.m. This year’s topic is “TheCampaign for Parity.” Plenary speakersinclude Congresswoman Mary Bono Mack(R-CA), Nancy H. Neilsen, M.D., Ph.D., Presi-dent of the American Medical Association,David Rosenbloom, Ph.D., President of theNational Center on Addiction and SubstanceAbuse at Columbia University, and EricGoplerud, Ph.D., Director of Ensuring solutionsto Alcohol Problems.

AWARDS LUNCHEON. Also on Saturday,the ASAM Awards Luncheon, set for 12:15to 2:00 p.m., honors outstanding individualshave made notable contributions to theSociety and to addiction medicine. A tradi-tional highlight of the luncheon is the JohnP. McGovern Award on Addiction and Society,established in 1997 to honor an individualwho has made highly meritorious contribu-tions to public policy, treatment, research,or prevention and who has increased ourunderstanding of the relationship of addic-tion and society. The award is sponsored byan endowment from the John P. McGovernFoundation. This year’s recipient is Congress-man Patrick J. Kennedy, in recognition of histireless efforts on behalf of parity for mentalhealth and addiction treatment. (The AwardsLuncheon is an extra fee event; businessattire is requested.) See pages 6-9 for moreinformation on the Med-Sci program.

Accreditation Council for Continuing Medical Education (ACCME). TheAmerican Society of Addiction Medicine is accredited by the AccreditationCouncil for continuing medical education to sponsor continuing medicaleducation for physicians.

American Medical Association (AMA). The American Society of AddictionMedicine designates this continuing medical education activity for a maximum of20 credit hours in Category 1 toward the AMA Physician’s Recognition Award.The Ruth Fox Course for Physicians and Pain and Addiction: Common Threads Xeach have been designated for an additional 8 credit hours. Each physicianshould claim only those hours of credit that he/she actually spent in the activity.

American Psychological Association (APA). The American Society of AddictionMedicine (ASAM)’s Continuing Medical Education (CME) has been approved forrenewal of certification by the APA College of Professional Psychology. ASAMCME credits may be applied toward the APA’s “Certificate of Proficiency in theTreatment of Alcohol and Other Psychoactive Substance Use Disorders.”

National Association of Alcoholism and Drug Abuse Counselors (NAADAC).ASAM has been approved as a National Association of Alcoholism and DrugAbuse Counselors (NAADAC) Education Provider, #152. Those who are applyingfor NAADAC credit should report their hours directly to NAADAC.

CONTINUING EDUCATION CREDITS AVAILABLEMed-Sci registrants are eligible for continuing education credits from ASAM and other organizations.

Med-Sci 2009 7

MED-SCI CONFERENCE

SPECIAL SESSIONS OPEN ASAM MEETINGThe following social and educational events on Thursday evening, April 30th, kick off ASAM’s Annual Medical-Scientific Conference in New Orleans:

Thursday, 5:00 - 6:00 p.m.

New Members’ Welcome ReceptionSponsored by Loma Linda University Behavioral Medicine Center, Redlands, CA

Thursday, 6:00 - 8:00 p.m.

Welcoming Reception and Opening of ASAM Exhibit HallSponsored by the Louisiana Chapter of ASAM

Thursday, 7:00 - 9:00 p.m.

Chapters Council MeetingIn addition to the general meeting, individual chapters will meet throughout theMed-Sci Conference. See the ASAM Registration Desk for a schedule.

Thursday, 8:00 - 10:00 pm

COMPONENT SESSION I: AA in Vivo —Workshop in the Twelve-Step Recovery Action GroupThis session affords a unique opportunity to participants to experience both an invivo observation of a Twelve-Step group, and analysis of the Twelve-Step experiencebased on what has been observed. The workshops will be held in a “fishbowl” format,wherein members of Twelve Step programs who are in recovery will carry out ameeting with a format typical of many Twelve-Step groups. This will allow workshopattendees to observe a close facsimile of the actual Twelve-Step experience.

COMPONENT SESSION II: Update on the ASAM PatientPlacement CriteriaThis session will focus on the evolving role and use of the ASAM Patient PlacementCriteria (PPC), as well as future directions for its development. While the ASAMCriteria have been adopted throughout much of the U.S. as the standard foraddiction placement and treatment matching, their implementation in differentsettings continue to be highly variable.

COMPONENT SESSION III: Moving Addiction Medicine intoFamily MedicineThe purpose of this session is to present current activities of the ASAM familymedicine work group, to solicit input from ASAM members who are primary carephysicians, and to develop goals for our group for the next year.

COMPONENT SESSION IV: Opioid Agonist Treatment —Training, Clinical Practice and Policy InitiativesIn this session, a panel of experienced clinicians, educators and policy makers willpresent an updated review of current clinical, training and policy issues in opioidagonist treatment and answer questions from the audience.

COMPONENT SESSION V: Public Policy in Addiction Medicine —Past, Present, and Future Addiction Medicine as a professional disciplinehas developed into today’s medical specialty through a number of scientific andpublic policy accomplishments over the past 30 years. ASAM officers past andpresent will review current and future public policy concerns. Participants arestrongly encouraged to share their views on the work of the Public Policy Committeeover the past five years, to discuss public policy statements under consideration,and to help the Public Policy Committee chart a course for the future.

MUTUAL HELP MEETINGSMutual help meetings will be held each morningand evening of the conference in the York Room.

Meeting times will be listed in the finalconference program, or check at the

Conference Registration Desk.

WOULD YOU LIKE A RECORDING OF A MEMORABLEPRESENTATION TO ADD TO YOUR PROFESSIONAL LIBRARY?

Recordings of sessions at the Med-Sci conference, the Common Threads course,and the Ruth Fox course can be purchased on-site or ordered from

Digital Conference Providers at 630-963-8311.

CONFERENCE REGISTRATIONOn-site registration will open from 5:00 to 7:00 p.m.

on Wednesday, April 29th, and from 7:00 a.m. to 7:00 p.m.on Thursday, April 30th.

NEW MEETING SCHEDULEIn a departure from past Med-Sci Conferences,

the ASAM Board of Directors will meet at 6:00 p.m.Monday, April 27th and all day Tuesday, April 28th.

All ASAM Committee and Council Meetings willtake place on Wednesday, April 29, 2009.


MED-SCI CONFERENCE DAILY PLANNER

DAILY PLANNERAll events will take place in the Hilton New Orleans Riverside Hotel.

5:00 – 6:00 pm❑ RUTH FOX COURSE FOR PHYSICIANSCo-Chairs: Margaret A.E. Jarvis, M.D., FASAM; John C. Tanner, D.O., FASAM;Speakers: Steven C. Boles, D.O., FASAM; Anthony H. Dekker, D.O., FASAM;John P. Femino, M.D., FASAM; Stanley E. Gitlow, M.D., FASAM; Margaret A.E. Jarvis, M.D.,FASAM; Marla D. Kushner, D.O., FASAM; Brian J. McDevitt, D.O., FASAM;John C. Tanner, D.O., FASAM; Michael F. Weaver, M.D., FASAM5:00 – 6:00 pm❑ PAIN AND ADDICTION: COMMON THREADS XCo-Chairs: Herbert Malinoff, M.D., FACP, FASAM; Edwin A. Salsitz, M.D., FASAM;Speakers: Daniel J. Clauw, M.D.; Harold M. Ginzburg, M.D.; Howard A. Heit, M.D.,FACP, FASAM; Herbert L. Malinoff, M.D., FACP, FASAM; Melvin I. Pohl, M.D., FASAM;A. Kenison Roy, III, M.D., FASAM; Edwin A. Salsitz, M.D., FASAM; Andrew J. Saxon, M.D.;Howard C. Wetsman, M.D.; Penelope P. Ziegler, M.D., FASAM5:00 – 6:00 pm❑ NEW MEMBERS’ WELCOME RECEPTIONSponsored by Loma Linda University Behavioral Medicine Center, Redlands, CA6:00 – 8:00 pm❑ WELCOMING RECEPTION AND OPENING OF THE ASAM EXHIBIT HALLSponsored by the Louisiana Chapter of ASAM7:00 – 9:00 pm❑ CHAPTERS COUNCIL MEETINGSpecific chapter meetings will be available throughout the Med-Sci Conference.Further information will be available at the Conference Registration Desk.8:00 – 10:00 pm❑ COMPONENT SESSION I: AA in Vivo — Workshop in the Twelve-Step RecoveryAction GroupChair: Marc Galanter, M.D., FASAM; Speakers: Marc Galanter, M.D., FASAM;Penelope Ziegler, M.D.; Richard K. Ries, M.D.8:00 – 10:00 pm❑ COMPONENT SESSION II: Update on the ASAM Patient Placement CriteriaChair: Marc J. Fishman M.D.; Speakers: David Mee-Lee M.D.; George Kolodner, M.D.;Gerald Shulman, M.A., FACATA8:00 – 10:00 pm❑ COMPONENT SESSION III: Moving Addiction Medicine into Family MedicineChair: Norman Wetterau, M.D., FAAFP, FASAM; Speakers: Richard Blondell, M.D.;Anthony Cloy, M.D.8:00 – 10:00 pm❑ COMPONENT SESSION IV: Opioid Agonist Treatment —Training, Clinical Practice and Policy InitiativesChair: Daniel P. Alford, M.D., M.P.H., FACP; Speakers: Andrew J. Saxon, M.D., EdwinSalsitz, M.D., FASAM; Adam J. Gordon, M.D., M.P.H., FASAM; Daniel Alford, M.D.,M.P.H., FACP; Laura F. McNicholas, M.D., Ph.D.; John A. Renner, Jr., M.D., DFAPA8:00 – 10:00 pm❑ COMPONENT SESSION V: Public Policy in Addiction Medicine —Past, Present, and FutureCo-Chairs: A. Kenison Roy, M.D., FASAM; Petros Levounis, M.D., M.A.; Mark L. Kraus,M.D., FASAM; Speakers: Mark L. Kraus, M.D., FASAM; Petros Levounis, M.D., M.A.;David E. Smith, M.D., FASAM; Louis E. Baxter, Sr., M.D., FASAM

7:30 – 9:00 am❑ ASAM ANNUAL BUSINESS MEETING & BREAKFAST(ASAM Members only — breakfast service will start at 7:15 am)Sponsored by the Christopher D. Smithers Foundation9:00 – 10:30 am❑ OPENING SCIENTIFIC PLENARY AND DISTINGUISHED SCIENTIST LECTURE AWARDFeaturing the Distinguished Scientist Lecture on “Spirituality, Social Affiliation, andAlcoholics Anonymous: Broadening the Base of Empirical Medicine” by Marc Galanter,M.D., FASAM, Director of the Division of Alcoholism and Drug Abuse, New YorkUniversity School of Medicine.10:30 – 11:00 am❑ REFRESHMENT BREAK — ASAM EXHIBIT HALL11:00 am – 1:00 pm❑ SYMPOSIUM 1: Update on Genetics and NeuroscienceSponsored by the National Institute on Alcohol Abuse and Alcoholism (NIAAA)Organizer: Mark Willenbring, M.D.11:00 am – 1:00 pm❑ SYMPOSIUM 2: Harm and Risk Reduction: Reaching Out or Tolerating Drug Use?Organizer: Michael Fingerhood, M.D., FACP; Speakers: Josiah D. Rich, M.D., M.P.H.;David Vlahov, Ph.D., R.N.; Susan G. Sherman, Ph.D., M.P.H.; Chris Serio-Chapman

11:00 am – 1:00 pm❑ PAPER SESSION I

• A Randomized Controlled Trial of Naltrexone Implants and Methadone MaintenanceAmong Heroin Dependent Inmates: Results 6 Months After Prison ReleasePresenter: Philip P. Lobmaier, M.D., Norwegian Centre for Addiction Research,University of Oslo, Norway (Recipient of the 2009 Young Investigator Award)• Acceptance of a Recovery Monitoring Check-Up (RMC) Program FollowingResidential Addiction Treatment: The Crossroads Aftercare & Recovery Evaluation(CARE) ProgramPresenter: T.C. Martin, M.D., FASAM, Crossroads Centre Antigua• Substance Abuse Screening in the 21st Century: A Pilot Study of aComputerized, Self-Administered ASSISTPresenter: Suzanne Spear, M.S., Integrated Substance Abuse Programs, Semel Institutefor Neuroscience and Human Behavior, David Geffen School of Medicine at UCLA• Gender Difference in Opioid Detoxification Using Buprenorphine/Naloxone in aPrivate Primary Care Family PracticePresenter: Richard V. Guzzetta, M.D., Touchstone Medical Group• Extended-Release Naltrexone for Treatment of Alcohol Dependence in UrbanPrimary Care: Feasible and AcceptablePresenter: Joshua D. Lee, M.D., M.Sc., New York University School of Medicine• Neurocognitive Enhancement for the Treatment of Chronic Pain in ChemicallyDependent PatientsPresenter: Peter Przekop, D.O., Ph.D., Departments of Psychiatry and Child Neurology,Loma Linda Medical Center

11:00 am – 1:00 pm❑ COURSE 1: Creating Emotional Competence in Addicts with PTSDOrganizer: M. Deborah Corley, Ph.D.; Speakers: M. Deborah Corley, Ph.D.;James C. “Jes” Montgomery, M.D.11:00 am – 1:00 pm❑ WORKSHOP A: Drugged Driving: Major Public Safety Threat & TreatmentOpportunity Organizer: Robert L. DuPont, M.D.., FASAM;Speakers: J. Michael Walsh, Ph.D.; Mark S. Gold, M.D.; Mark L. Kraus, M.D., FASAM11:00 am – 1:00 pm❑ WORKSHOP B: Integrating Smoking Cessation into Chemical DependenceTreatment Organizer: Steven Kipnis M.D., FACP, FASAM; Speakers: Carl RollynnSullivan, M.D.; Joseph Guydish, Ph.D.; Steven Kipnis M.D., FACP, FASAM1:00 – 3:00 pm❑ LUNCH BREAK1:30 – 2:30 pm❑ POSTER SESSION — Exhibit Hall(refer to the full Conference program for a list of posters and first authors)3:00 – 5:00 pm❑ SYMPOSIUM 1 continued — Update on Genetics and NeuroscienceSponsored by the National Institute on Alcohol Abuse and Alcoholism (NIAAA)3:00 – 5:00 pm❑ SYMPOSIUM 3: Medical Marijuana RevisitedOrganizer: Gregory C. Bunt, M.D.;Speakers: J.H. Atkinson, M.D.; Robert L. DuPont, M.D., FASAM; Jag Khalsa, Ph.D.3:00 – 5:00 pm❑ Paper Session II

• Safety and Efficacy of Probuphine®, a 6-Month Sustained-Release Formulation ofBuprenorphine for the Treatment of Opioid Addiction: A Phase 3, Double-Blind,Placebo-Controlled Study. Presenter: Walter Ling, M.D., Professor of Psychiatryand Director, Integrated Substance Abuse Programs, Department of Psychiatry &Biobehavioral Sciences, David Geffen School of Medicine at UCLA (Recipient of theMedical-Scientific Conference Program Committee Award)• Pain, Addiction and Risk Management in Your Community: Concepts and Tools toHelp Patients and Improve Outcomes.Presenter: Jennifer Michaels, M.D., Assistant Professor, University of MassachusettsMedical School• One Year of Sustained-Release Naltrexone Treatment for Opioid Dependence.Presenter: Nikolaj Kunoe, Clinical Psychologist, Norwegian Centre for Addiction Research,University of Oslo, Norway• Opioid Agonist Challenges to Naltrexone Blockade Among Poly-Drug UsingNaltrexone Implant Patients.Presenter: Nikolaj Kunoe, Clinical Psychologist, Norwegian Centre for Addiction Research,University of Oslo, Norway• Pharmacokinetic Analysis of Plasma Buprenorphine in Patients With OpioidAddictionTreated for 6 Months With Either Probuphine® or Placebo Implants. Presenter:Mark Greenwald, Ph.D.• Prescription Medication Overdose Deaths Among Females in Rural Virginia,1997 – 2004.Presenter: Martha J. Wunsch, M.D., Associate Professor, Department of BehavioralScience, Center for Drug and Alcohol Research, University of Kentucky, Lexington, KY

FR

IDA

YT

HU

RS

DA

Y

FR

IDA

Y

Med-Sci 2009 9

MED-SCI CONFERENCE DAILY PLANNER

3:00 – 5:00 pm❑ WORKSHOP C: Cocaine and Methamphetamine Addiction — Clinical Update 2009Organizer: Arnold M. Washton, Ph.D.; Speakers: Mark S. Gold, M.D.;Richard A. Rawson, Ph.D.; Joan E. Zweben, Ph.D.; Arnold M. Washton, Ph.D.3:00 – 5:00 pm❑ WORKSHOP D: Alcohol Blackouts Revisited — Recent AdvancesOrganizer: Charles L. Whitfield M.D., FASAM;Speakers: Charles L. Whitfield, M.D., FASAM; Donald F. Sweeney M.D., FASAM, FACP3:00 - 5:00 pm❑ SYMPOSIUM 4: Point/Counterpoint — Forum to Explore Controversies inMedication-Maintained Recovery with Opioid DependenceOrganizers: Mel Pohl, M.D.; Richard Ries, M.D.;Speakers: Vern R. Williams, M.D.; Karen Miotto, M.D.; Daniel P. Alford, M.D., M.P.H., FACP6:30 – 8:30 pm❑ RUTH FOX ENDOWMENT RECEPTION (by invitation only)Sponsored by Dr. & Mr. Joseph E. Dorsey and Dr. Tommie F. Lauer8:00 – 10:00 pm❑ WORKSHOP E: Psychotherapeutic Benefits of Opioid Agonist TherapyOrganizer and Speakerr: Peter L. Tenore, M.D., FASAM8:00 – 10:00 pm❑ WORKSHOP F: Chronic Hepatitis C — Evidence-Based Therapy in Patientswith Co-Existing Severe Mental Illness and Substance Use DisordersOrganizer and Speaker: Ken Freedman, M.D., M.S., M.B.A., FACP, FASAM8:00 – 10:00 pm❑ WORKSHOP G: Physician Health Programs — The Evidence and Implicationsfor the Future of Care Management of Substance Use DisordersOrganizer: Robert L. DuPont, M.D., FASAM;Speakers: Gregory E. Skipper, M.D.; Louis E. Baxter, Sr., M.D., FASAM9:30 pm❑ ASAM DESSERT AND COFFEE RECEPTIONSponsored by Pine Grove, Hattiesburg, Mississippi, and Alkermes, Inc.,Cambridge, Massachusetts

7:00 – 8:00 am❑ CONTINENTAL BREAKFAST — ASAM Exhibit HallSponsored by Alkermes, Inc.8:00 – 9:30 am❑ POLICY PLENARY — CAMPAIGN FOR PARITYOrganizers: A. Kenison Roy III, M.D., FASAM; Mark L. Kraus, M.D., FASAM;Petros Levounis, M.D., M.A., FASAM.Keynote address: Nancy H. Neilsen, M.D., Ph.D., President of the AmericanMedical Association10:00 am – 12 Noon❑ SYMPOSIUM 5: Use of Opioids for the Treatment of Chronic Pain: CurrentEvidence, Practices and Future DirectionsSponsored by the National Institute on Drug Abuse (NIDA)Organizers: Norman Wetterau, M.D., FAAFP, FASAM; Richard A. Denisco, M.D., M.P.H.;Speakers: Michael R. Von Korff, Ph.D.; Andrew Rosenblum, Ph.D.; Richard A. Denisco,M.D., M.P.H.; Mathew Devine, D.O.10:00 am – 12 Noon❑ SYMPOSIUM 6: Improving Outcomes by Using Evidence-Based Practices —The New Science of ImplementationOrganizer: Joan Zweben, Ph.D.;Speakers: Joan Zweben, Ph.D.; Wilson M. Compton, M.D., MPE; Jack B. Stein, Ph.D.10:00 am – 12 Noon❑ COURSE 2: Understanding the Symbiotic Relationship Between Cocaine andHIV — How Do We Break Up This Relationship?Organizer: Megan M. Pinkston, M.A., Ph.D.; Speakers: Megan M. Pinkston, M.A., Ph.D.;Jennifer Mitty, M.D., M.P.H.; Nick Zaller, Ph.D.; Cynthia MacLeod, B.S.N., ACRN, CARN10:00 am – 12 Noon❑ WORKSHOP H: Nonmedical Use of Prescribed Controlled Substances byCollege Students — Prevention OpportunitiesOrganizer: Robert L. DuPont, M.D.., FASAM;Speakers: Amelia M. Arria, Ph.D.; Mark S. Gold, M.D.; David E. Smith, M.D., FASAM10:00 am – 12 Noon❑ WORKSHOP I: Treatment of Fetal Alcohol Syndrome and Fetal Alcohol SpectrumDisorders in the Addiction Practice — Etiology, Screening, Comorbid Diagnosisand Long Term ManagementOrganizer: Martha J. Wunsch, M.D.;Speakers: Martha J. Wunsch, M.D.; Susan Adubato, Ph.D.; Mary DeJoseph, D.O.12:15 — 2:00 pm❑ ASAM AWARDS LUNCHEON AND ABAM CERTIFICATION RECOGNITIONIn memory of LeClair Bissell, M.D., Ronald M. Davis, M.D., and Martin C. Doot, M.D.,FASAM (Ticketed event — $55 per person)

2:00 – 4:00 pm❑ SYMPOSIUM 5 — continuedUse of Opioids for the Treatment of Chronic Pain — Current Evidence,Practices and Future DirectionsSponsored by the National Institute on Drug Abuse (NIDA)2:00 – 4:00 pm❑ SYMPOSIUM 7: Homelessness and Addiction — Innovations in Clinical Practiceand Policy for a Challenging PopulationOrganizer: Jeffrey H. Samet, M.D., M.A., M.P.H.;Speakers: Stefan G. Kertesz, M.D., M.Sc.; Anita Palepu, M.D., M.P.H., FRCPC;Adam J. Gordon, M.D., M.P.H., FACP, FASAM2:00 – 4:00 pm❑ SYMPOSIUM 8: What is Addiction? What is Recovery?Organizers: Richard N. Rosenthal, M.D.; Donald J. Kurth, M.D., M.B.A., M.P.A., FASAM;Speakers: Richard N. Rosenthal, M.D.; Donald J. Kurth, M.D., M.A., M.P.A., FASAM;George F. Koob, Ph.D.2:00 – 4:00 pm❑ SYMPOSIUM 9: Unique Models for Comprehensive Substance Abuse Treatment— Joint Session With the International Society of Addiction MedicineOrganizers: Marc Galanter, M.D.; Jag H. Khalsa, Ph.D.;Speakers: John Strang, M.D., National Addiction Centre, The Maudsley Institute ofPsychiatry, London, England; Evgeny Krupitsky, M.D., Ph.D., D.Med.Sci., Chief,Laboratory of Clinical Psychopharmocology of Addictions, Bekhterev ResearchPsychoneurological Institute, St. Petersburg, Russia; Thorarinn Tyrfingsson, M.D.,Director, Vogur Hospital, Storhofda, Iceland2:00 – 4:00 pm❑ WORKSHOP J: Focus on Recovery, Not Just Treatment of AddictionOrganizer: Dennis C. Daley, Ph.D.; Speakers: Dennis C. Daley, Ph.D.; Antoine Douaihy, M.D.2:00 – 4:00 pm❑ WORKSHOP K: Making the Leap — Actual Implementation of ConcurrentDisorder Treatment Programs for Patients with Severe Mental Illness and AddictionOrganizer: Shaohua Lu, M.D., FRCPC;Speakers: Shaohua Lu, M.D., FRCPC; Heather Robertson, M.D., FRCPC;Stephen Holliday, Ph.D., R,Psych; Annabel Mead, M.D.2:00 – 4:00 pm❑ WORKSHOP L: The Maternal-Fetal Dyad — Perinatal Treatment of OpioidDependency in the Mother and NewbornOrganizer: Catherine Friedman, M.D.;Speakers: Debra Bogen, M.D.; Melinda Campopiano, M.D.; Catherine Friedman, M.D.3:00 pm❑ EXHIBIT HALL CLOSES4:00 – 6:00 pm❑ COURSE 3: Double Trouble — Stimulant Treatment of Co-Occuring ADHDand SUD (An Update)Organizer and Speaker: Anthony M. Ocana, M.Sc.4:00 – 6:00 pm❑ COURSE 4: Buprenorphine for the Treatment of Acute and Chronic PainOrganizer: Terry A. Rustin, M.D.; Speakers: Terry A. Rustin, M.D.; Jason Powers, M.D.

8:00 – 10:00 am❑ FORUM ON WHETHER ASAM SHOULD ESTABLISH A NON-PHYSICIAN CATEGORYOF MEMBERSHIPOrganizers: ASAM Membership Committee8:00 – 10:00 am❑ WORKSHOP M: Pain, Addiction and Risk Management in Your Community —Concepts and Tools to Help Patients and Improve OutcomeOrganizer: Jennifer Michaels, M.D.;Speakers: Jennifer Michaels, M.D.; Alexander Sabo, M.D.; John Rogers, Esq.8:00 – 10:00 am❑ SYMPOSIUM 12: Substance Abuse and Associated ComorbiditiesOrganizers: Lawrence S. Brown, Jr., M.D., M.P.H., FASAM; Jag H. Khalsa, Ph.D.;Speakers: Michael J. Taylor, Ph.D.; Shenghan Lai, M.D.; Dave Thomas, M.D.; MarkSulkowski, M.D.; Glenn Treisman, M.D.; Glen Hanson, M.D.; Christine Wanke, M.D.;Frank Vocci, M.D.; Elinore McCance-Katz, M.D.10:00 am – Noon❑ SYMPOSIUM 10: Co-Occurring Post-Traumatic Stress Disorder and AddictionsOrganizer: Kathleen Brady, M.D., Ph.D.;Speakers: Kathleen Brady, M.D., Ph.D.; Thomas Kosten, M.D.; Wilson Compton, M.D., M.P.E.10 am – Noon❑ SYMPOSIUM 11: Sleep and AddictionOrganizer: R. Jeffrey Goldsmith M.D., DFAPA; Speakers: Douglas Moul, M.D.;Michael Varenbut, M.D., CCSAM, MRO, FASAM; Jeff Daiter, M.D., CCFP, FCFP12 Noon❑ CONFERENCE ENDS

SA

TU

RD

AY

FR

IDA

Y

SU

ND

AY

SA

TU

RD

AY


ASAM CERTIFICATION

CERTIFIED INADDICTION MEDICINEAdebukola Omotoso Abiola, M.D.Gregory Alexander Acampora, M.D.William Joaquin Adamas-Rappaport, M.D.Akinola O. Adebisi, M.D.Adegoke Adeyinka Adeyemo, M.D.Hoover Adger, Jr., M.D., M.P.H., M.B.A.Kami Adibi, M.D.Lawrence Ogagaoghene Adu, M.D.Mahmoud Mostafa Ahmed, M.D.Nadejda Alekseeva, M.D.Arthur Mark Altbuch, M.D.Arastou Aminzadeh, M.D.William G. Anderson, M.D.Guadalupe Aranguena-Sharpe, M.D.Albert Joseph Arias, M.D.John Anthony Bailey, M.D.Brian David Barash, M.D.David Lawrence Beck, M.D.Cesar Luis Benarroche, M.D.Timothy Gerard Benson, M.D.Daniel William Berland, M.D.Elizabeth Bhargava, M.D.Suzy Bibawy, M.D.Sherrie Ann Bieniek, M.D.Jill K. Billions, M.D.James E. Black, M.D., Ph.D.Robert Livingston Boyd, M.D.Mary Shealy Boyd, M.D.Greg A. Brown, M.D.Robert Douglas Bruce, M.D., M.A., M.S.Ann Bruner, M.D.Joan Elizabeth Brunson, M.D.Judy Ann Burk, M.D.Neil Prakash Butani, M.D.Jeffrey W. Buttle, M.D., FRCP(C)Jeffrey Lee Butts, D.O.Stephen Lee Byrd, M.D.Richard Anthony Campana, M.D.Melinda Marie Campopiano, M.D.Richard H. Carmona, M.D., M.P.H.Michael Anthony Carnevale, D.O.Carlos Rafael Carretero, M.D.Ian Richard Carroll, M.D.Laurie Rashidi Casaus, M.D.Barbara Herman Center, M.D.Maureen Nicole Ceresney, M.D.,FRCPCMichael Louis Cesta, M.D.Robert Andrew Chambers, M.D.

317 Physicians Earn ASAM Certification;81 Are Recertified in Addiction Medicine

ASAM’s Certification Council has announced that the following physicians meet the requirements for ASAM Certificationor Recertification in Addiction Medicine. Their achievement will be recognized at the Awards Luncheon during ASAM’s

40th Annual Medical Scientific Conference. The luncheon is scheduled for 12:00 noon on Saturday, May 2nd.

Laura Mae Chapman, M.D.Amina Chaudhry, M.D.Sreekrishna M. Cheruvu, M.D.David Chim, D.O.Angelo Chirban, M.D.Yasin Mohsin Choudry, M.D.Indra Kumar Cidambi, M.D.Josie Ann Cigarroa, M.D.Aaron Jason Cleveland, M.D.Nelson Collins, M.D.Eric D. Collins, M.D.Hubert Anthony Colohan, M.D.,BAO,

BCh, LMCC,Kevin Paul Cotterell, M.D.Joseph Cox, M.D., MSc, FRCP(C)Benita L. Cushingberry-Turner, M.D.Gail D’Onofrio, M.D., M.S., FACEMItai Danovitch, M.D.Christopher Jackson Davis, D.O.Timothy Charles Dawson, M.D.Antonio F. De Filippo, M.D.Paula Vanessa De La Cruz, M.D.Michael Anthony Denicole, D.O.Krisanna Lee Deppen, M.D.Juan Carlos DeVirgiliis, M.D.Gregory Oran Dill, M.D.Greg C. Dobash, M.D.James Stonewall Dorsey, M.D.Mario Douyon De Azevedo, M.D.Mary Dowd, M.D.David M. Dranetz, M.D.Bridget P. Early, M.D.John Charles Echols, M.D.Sherif Samy El Asyouty, M.D.Gregory Lee Ellison, M.D.Ashraf Elshafei, M.D.Todd H. Engles, M.D.Mary Ann Evans, M.D.Daniel Rey Faber, M.D.Richard L. Falzone, M.D.Carl Alvin Faulks, M.D.Susan Callaway Ferguson, M.D., M.S.Lyle Beverly Forehand, Jr., M.D.Thomas Neil Franklin, M.D.Lawrence Frederick Fredeen, M.D.,

CCFP BScGregory Eugene Freed, M.D.David Arthur Frenz, M.D.Robert Zachery Friedman, M.D.Katya Frischer, M.D.

Mary Elizabeth Fry, M.D.Carl Edward Fulwiler, M.D.Joseph Michael Garbely, D.O.Larry M. Gentilello, M.D., FACSJason Erik Giles, M.D.Trevor Allan Gillmore, M.D.Daniel M. Glick, M.D.James William Golden, M.D.Harry David Goldwasser, M.D.Eugene S. Gorman, M.D.Jon Edgar Grant, M.D.,J.D.William Samuel Grass, M.D.William Morgan Greene, M.D.Barry Jan Gross, D.O.Brian Guan, M.D., FRCP(C)Jeffrey Alan Gudin, M.D.Rajesh Gupta, M.D.Asif Habib, M.D.Elizabeth VanDeCarr Hakas, M.D.Phillip Bradley Hall, M.D.Lacresha L. Hall, M.D.Scott Lewis Hambleton, M.D.Abode Latif Hamoush, M.D.Muhammad Abdur Rahim Haqqani, M.D.Kristina Joan Harrington, M.D.Nzinga Ajabu Harrison, M.D.Susan Harper Hart, M.D.Marcel Hediger, M.D., MBChB, MMedAndrea L. Hedin, M.D.Keith Gregory Heinzerling, M.D., M.P.H.Michael Douglas Hellman, Sr., M.D.Anil Raghunathprasad Hinnaria, M.D.Lara Leah Hodel, M.D.Matthew Elton Holmes, M.D.Clark S. Homan, M.D.Scott James Hompland, D.O.Mark Hrymoc, M.D.Jeffrey Hsien-Min Hsu, M.D.Seema Hussain, M.D.Rostislav Ignatov, M.D.Babak Imanoel, D.O.Saif U. Jaffery, M.D.William Anthony Jamack, D.O.Robert Royce Johnson, D.O.Douglas Edgar Jones, M.D.Jill Shawn Jones, M.D.Lantie Elisabeth Jorandby-Quinones, M.D.Sheldon Emanuel Jordan, M.D.Maralee Joseph, M.D.Tony Juneja, M.D.

Abigail Kay, M.D.Bobby Paxton Kearney, M.D.William Joseph Keating, M.D.Saeed-Uz Zafar Khan, M.D.Alice Rosalyn Kim, D.O.Charles Benjamin King, M.D.Andrzej Bohdan Koczapski, M.D.Grace N. Kooper, M.D.Vinaya S. Koppikar, M.D.Shiva Kumar Kotturi, M.D.Andrew G. Kowal, M.D.Anthony Kozma, D.O.David Randall Kramer, M.D.Ashok Bellur Krishnamurthy, M.D.Timothy Joseph Kross, M.D.Jonathan D. Kunis, M.D.Selahattin Said Kurter, M.D.Matthew Charles Lally, M.D.William Charles Leach, M.D.Lisa Gwyneira Lefebvre, M.D.Andrew E. Leifer, M.D.Peter Leong, M.D.Leonard Lev, M.D.Laura Beth Levine, M.D.Allan L. Levy, M.D.Michael Ian Liebowitz, M.D.Thomas Lincoln, M.D.Christopher James Linden, M.D.Dmitry Vito Listengarten, M.D.Michelle Renee Lofwall, M.D.Theodore P. Logan, M.D.Daniel Philip Logan, M.D.Manuel Lopez-Leon, M.D.James Whitton Lowe, M.D.Ronald Fraser MacKay, M.D.,

MCFP(EM),FACEPBrian Andrew Mahoney, M.D.Joseph S. Mardis, M.D.Curtis R. Markham, M.D.John Stuart Martin, M.D.John William Martyniuk, Ph. D., M.D.Robert John Masone, M.D.Christopher Martin Matkovic, M.D.Joseph Montgomery Matta, M.D.Earl John Delacruz Mauricio, M.D.Nancy Ann McCarthy, M.D.William Joseph McCreight, M.D.Duncan J. McEwen, M.D.William Aloysius McLaughlin, M.D.Andrew Bruce Mendenhall, M.D.

Med-Sci 2009 11

Jeremy Shawn Mirabile, M.D.Robert Bond Molpus, M.D.Aldo Morales, Jr., M.D.Robert Allen Moran, M.D.William R. Morrone, D.O.Patricia Lynn Mullen, M.D.Paul Gerard George Mulzer, M.D.Michael Thomas Mumford, M.D.Christopher John Murphy, M.D.Emlene Mary Murphy, M.D., FRCP (C)Laura Anne Murray, D.O.Syed Kamal Mustafa, M.D.Jefferson Edward Nelson, M.D.William C. Nemeth, M.D.John T. Netterville, Jr., M.D.Thomas Anh Nguyen, M.D.Edward V. Nunes, Jr., M.D.Jairo Rafael Nunez, M.D.Patrick G. O’Connor, M.D., M.P.H.Robert Charles Oelhaf, Jr., M.D.David Alan Onsrud, D.O.Adegboyega Adekunle Oyemade, M.D.Michael S. Parr, M.D.Kevin Mark Passer, M.D.Trupti Vikram Patel, M.D.David Gordon Patrick, M.D.John F. Penfield, D.O.Eric Evan Petterson, M.D.Geoffrey Bryant Phillips, M.D.Nyk V. Pidhorodeckyj, M.D.Gregory Harold Pierce, M.D.Daniel Patrick Pisaniello, M.D.Soteri Polydorou, M.D.Ian Marshall Postnikoff, M.D.Anthony Joseph Preston, M.D., BCh,

BAO, LMCCRick L. Pullen, D.OFaraz Qureshi, M.D.Sina Radparvar, M.D.Branko Radulovacki, M.D.Sangeetha Raghuraman, M.D.Dheeraj Kanhayalal Raina, M.D.Babu K. Rankupalli, M.D.Edward Ratush, M.D.Asok Kumar Ray, M.D.Emily J. Rayes-Prince, M.D.Charles Paul Reznikoff, M.D.Joel Douglas Rice, M.D.Mark Riley, M.D.Heather Ann Robertson, M.D.Carolyn C. Ross, M.D.,M.P.H.Darren Rothschild, M.D.Dikea Roussos-Ross, M.D.Steven Francis Ruh, M.D.Carlos H. Ruiz, M.D.Kenneth Carl Russ, M.D.Mohammad Saeed, M.D.Mary Elizabeth Sage, M.D.Mandeep Singh Saini, M.D., MBChB

Paul I. Saladino, M.D.Jeffrey H. Samet, M.D., M.A., M.P.H.Subbu J. Sarma, M.D.Sajjad A. Savul, M.D.Steve Ross Scanlan, M.D.Karl Vincent Schroeder, M.D.Catherine Scott, M.D.Anca Seger, M.D.Hope Susan Selarnick, M.D.James Gordon Seymour, M.D.Randall Sherman, M.D.Pamela Jo Shultz, M.D.Amitabh Singh, M.D.John D. Six, M.D.Anna Skiandos, D.O.Robert Gordon Skwerer, M.D.David Hylton Smith, M.D.Gregory Dale Smith, M.D.Robert J. Sokol, M.D., FACOGLouis William Solomon, M.D.Ayodeji Somefun, M.D.Georgette Somjen, M.D.Leonard Morris Spishakoff, M.D.Lorinda G. Spooner, M.D.Michael Phillip Sprintz, D.O.Elizabeth Shirley Stanton, MD, MBA, FAPABruce M. Stark, M.D.Kevin William Stevenson, M.D.John Lawrence Stoune, M.D.Todd W. Stull, M.D.Daniel David Sumrok, M.D.,FAAFPMichael C. Susco, M.D.Dennis Swartout, M.D.Emjay M. Tan, M.D.Peter Theodoropoulos, M.D.Lucille Charmaine Thomas, M.D.John R. Thompson, M.D.Christopher Reveley Thompson, M.D.Carlos Francisco Tirado, M.D.Todd Masahiro Tomita, M.D.Reyes R. Topete, M.D.Jan Hendrik Trobisch, M.D.Phuong Chi Truong, M.D.Shakil Tukdi, M.D.Yana Michelle Van Arsdale, M.D., Ph.D.Monisha Rohitkumar Vasa, M.D.Gerrit Veenman, M.D.Nalini Velayudhan, D.O.Pamela L. Vincent, M.D.Joseph Glen Vitolo, M.D.Steven Todd Wallenius, M.D.Marta Karolina Wasiak, M.D.Robert W. Waterman, M.D.James Daniel Weathers, M.D.Dennis Dorr Weimer, M.D.Valerie Ann Westhead-Tonner, M.D.Charles Leo Michael Whelton, M.D.,

FRCP(C)Nancy Tarbox White, M.D.

William Dale White, M.D.John Bradford White, M.D.Susan Marie Wiet, M.D.Russell Gordon Williams, D.O.Darrel Lenard Wilson, M.D.David G. Wolff, M.D.Nick Neng Lih Wong, M.D.Xueming Lisa Ye, M.D.Lilit Yegiazaryan, M.D.Cindy S. Yeung, D.O.Jeffrey Arthur Yocum, D.O.Eugene Y. Young, D.O.He Yuan, M.D., Ph.D.Stephen John Zella, D.O.Aleksandra Zgierska, M.D., Ph. D.Daniel Jeffrey Zimmerman, M.D.

RECERTIFIED INADDICTION MEDICINENaved Asghar Ali, M.D.Maria Rita Aszalos, M.D.John A. Baker, III, M.D.Louis E. Baxter, Sr., M.D., FASAMWilliam Joseph Beals, M.D.James Edward Beckett, M.D.Ira Birnbaum, M.D.Richard Duane Blondell, M.D.Steven Charles Boles, D.O., FASAMJacqueline Denise Boutrouille, M.D.Cecil A. Bradley, M.D.David William Brook, M.D., FASAMJohn Nelson Campbell, M.D. PCMichael James Carraher, M.D., M.P.H.,

M.B.A.Sanjay Sreenivas Chandragiri, M.D.George Lewis Chappell, M.D.Stephen Christopher Clarke, M.D., B.Sc.William Michael Cochran, M.D.Alan Lee Dayno, M.D.Christina Maria Delos Reyes, M.D.Michael Lawrence Eisenberg, M.D., M.P.H.Mary Eno, M.D., M.P.H.Kenneth Ira Freedman, M.D., MBA,

FACP, FASAMBrenda Kaye Freeman, M.D.James Cameron Garbutt, M.D.Ivor Garlick, M.D.Ralph Ervin Gauen, M.D.Ralph Ervin Gauen, M.D.Stanley E. Gitlow, M.D., FACP, FASAMEliseo A. Go, M.D.Douglas L. Gourlay, M.D., FRCPC, FASAMJohn B. Griffin, Jr., M.D.Thomas Arthur Hauth, M.D.Richard Lewis Hinchman, M.D.Ivan Bruce Hoffman, M.D.John Alexander Hopper, M.D.Elizabeth Fulton Howell, M.D., FASAMLinda Mane Hueseman, M.D.

Robert B. Hunter, M.D., FASAME. Rackley Ivey, M.D.Alison Leslie Jacobi, M.D.Mark Getty Jameson, M.D.Margaret A. E. Jarvis, M.D., FASAMSteven Mark Jenkusky, M.D.Steven Jeffrey Kassels, M.D.Arlene M. Kellman, D.O.Joseph Allen Kwentus, M.D.Jessica A. Lay, M.D.Michael Roger Liepman, M.D., DFAPA,

FASAMLance Peter Longo, M.D., FASAMGeorgia Dora Lubben, M.D.George W. Luedke, M.D.Alan James Lynch, M.D.Robert Mallin, M.D.Narain Das Mandhan, M.D.Jean Anne Marsters, M.D.John Bryce McLaulin, M.D.Mark A. Menestrina, M.D., FASAMRobert Joseph Middleton, M.D., FACP,

FASAMShannon C. Miller, M.D., FASAM, CMROPamela Jean Moore, M.D.Karen Ann Moriah, M.D.Paul H. Musson, M.D.Harry P. Nguyen, M.D.James Paul O’Neill, MDChandrakant A. Patel, M.D.Jagannath J. Patil, M.D.David Roger Pating, M.D.Ashwin Anand Patkar, M.D.Dorota Katarzyna Poluha, M.D.Launette Marie Rieb, M.D.,MSc,

CCFP,FCSPAlphonse Kenison Roy, III, M.D., FASAMWilliam Sadowsky, M.D.Kenneth Andrew Saffier, M.D.Christopher Scandinaro, M.D.Peter L. Selby, MBBS, CCFP, FASAMRaymond Marc Shapiro, M.D.Suma Cherukuri Singh, M.D.J. Richard Spatafora, M.D.Duraiyah Thangathurai, M.D., FASAMRajakumar Thotakura, M.D.Donald D. Timmerman, M.D.Berton James Toews, M.D., FASAMJoseph Alder Troncale, M.D., FASAMNishendu M. Vasavada, M.D.James Joseph Vilt, Sr., M.D.Walter H. Wahl, M.D.Robert William Watrous, M.D.Michael F. Weaver, M.D., FASAMThea Marie Weisdorf, M.D.Robert B. Whitney, M.D.Robert Bruce Worth, M.D.Donna D. Yi, M.D.Rony Zodkevitch, M.D.

ASAM CERTIFICATION


ASAM MEMBERSHIP

Should Non-Physicians Be Admitted to Membership in ASAM?The Case FOR Associate Membership

Daniel J. McCullough, M.D., M.Phil., FAAFPand Brian Hurley, M.D., M.B.A., C0-Chairs, ASAM Membership Committee

Over the past few years, your Member-ship Committee has been consideringthe pros and cons of creating a new

category of Associate Member of ASAM.The calls for Associate Membership have

grown louder with the formation of theAmerican Board of Addiction Medicine andlast fall’s enactment of the Paul WellstoneMental Health and Addiction Parity Act.Many senior leaders of ASAM have voiced theopinion that arguments against AssociateMembership have been weakened by theseimpressive accomplishments.

At the Membership Committee, we havebeen charged with designing a new categoryof membership that would allow non-physician stakeholders in Addiction Medicineto become members of ASAM. Our Society’sincoming President, Dr. Louis Baxter, has toldus: “There are a number of reasons to offeran Associate Membership category, butperhaps one of the best reasons is to bringAddiction Medicine and treatment backunder the direction of physicians. In the earlydays, dating back to the 1970s, counselorsran addiction treatment and physiciansco-signed the “treatment plan.” Over thepast 25 years, physicians have begun to reas-sert medical leadership by taking leadershippositions in treatment facilities. Moreover,with the advent of medication-assisted thera-pies, it is becoming more important to actuallyhave Medical Directors and physician leader-ship. ASAM’s acceptance of non-physicianmembers will directly increase ASAM’s abilityto influence and guide the policies and bestpractice principles utilized in addiction treat-ment to a greater degree than we alreadyrealize and enjoy.”

What is Associate Membership? AssociateMembership would be a new membershipcategory that would be marketed to non-physicians who work in the addiction fieldor who have an interest in Addic tionMedicine topics. Associate Members wouldreceive the following benefits:

� Free access to ASAM News and theJournal of Addiction Medicine

� Discounts on registration fees formeetings, conferences, and onlineeducational programs

� Discounts for other ASAM publicationsand products

� Affiliation as a member of the Society.

Associate Members would not haveprivileges to:

� Sit on any ASAM committee (except withthe approval of the Board of Directors,as at present)

� Run for election to ASAM governanceposts (e.g., officer or member of theBoard of Directors)

� Vote in any ASAM election.

How would ASAM benefit from AssociateMembership? ASAM’s mission is to improvethe care and treatment of people with thedisease of addiction and to advance the prac-tice of Addiction Medicine. The treatment ofaddiction involves a multidisciplinary team ofpractitioners and partners, each of whomcontribute toward the common purpose ofproviding care. No medical society can operatein isolation and the proper locus of interac-tion is at the membership level, during ourmeetings. Associate membership reinforcesthe multi-disciplinary and collaborative natureof the addiction field within our medical society.

Expanding ASAM’s membership to includenon-physician members is an integral part ofa strategy to position ASAM as the premierorganizational voice for addiction medicine.By involving those who would contribute toour mission, we make ASAM the true“umbrella organization” or interaction groundfor discussion and debate, education, andadvocacy for Addiction Medicine practitio-ners and patients. Because the electedleadership of ASAM would continue to bedrawn from the ranks of physicians, we camretain the benefit of representing physiciansand physicians-in-training in the public eye.However, involving associate members createsreal opportunities to foster the multi-disciplinary approach required by the moderndelivery of addiction care.

How would Associate Members benefitfrom joining ASAM? Associate Memberships:

� Position ASAM as the umbrella grouprepresenting the entire practice ofAddiction Medicine (including alliedhealth professionals).

� Deliver ASAM’s educational content to abroader audience

� Bring the voice of our non-physicians part-ners to our meetings and educationalevents, making them an even more enrich-ing experience for all of our members.

� Enhance our credibility as an organiza-tion that promotes the appropriate roleof the physician in the care of patientswith addiction, as the leading memberof the multidisciplinary team.

� Open the possibility that ASAM couldplay a role in credentialing non-physicianin Addiction Medicine.

Other issues considered by the MembershipCommittee include:

� Marketability: Associate memberships arein demand by a number of market seg-ments, each of whom we can readily reachout to. Associate members are not askingfor governance roles; they are looking forthe tangible opportunity to connect withthe society.

� Financial sustainability: By reaching to abroader segment, this creates a broaderfinancial base for us to build the expandedwork we know must happen: parity,ABAM, state chapter expansion, et al. It isin our financial interest to bring in moremembers.

� Credibility: We retain our physiciancredibility by maintaining our physiciangovernance. However, we become morecredible when we leverage this credibilityand reach out to a broader membershipbase that is truly multi-disciplinary.

� The “slippery slope” argument: Manysocieties maintain associate membershipswith no breakdowns in governancestructure. ASAM would simply maintain ourchoice to remain physician governed toavoid the slippery slope of including non-physicians in governance.

This is an important decision for ASAM, andone that has multiple ramifications for thefuture of our Society. It is not one that we atthe Membership Committee take lightly.Therefore, we plan to conduct a formalmembership survey and to bring the resultsto the entire ASAM Board of Directors, whichwill make a final decision in October.

Med-Sci 2009 13

ASAM MEMBERSHIP

I present the following personal views asa friend of ASAM and a friend of Addic-tion Medicine. I write also as a friend of

every addicted person, and of every parentor relative who worries what to do about achild’s or spouse’s or family member’s alcoholor other drug use, and who, in hope of help,may visit his or her physician, only to find thatthe physician is at a loss for what to say ordo, because the physician has had no educa-tion or training in Addiction Medicine.

Has ASAM achieved its primary mission, sothat it can go on to a new mission? The onlyscenario in which I could see ASAM havingnon-physician or non-medical student mem-bers is one in which the ASAM leadership andmembers can say that ASAM has accom-plished its mission to educate physicians andmedical students about the prevention andtreatment of alcoholism and other addictions(ASAM Constitution, Article 1. Section 2. Pur-poses). The fact that there are more than800,000 physicians in the U.S. but only 3,000ASAM members (.00375%) should instill sucha sense of mission-urgency among the ASAMleadership, membership and staff that anysuggestion to recruit and educate non-physician members would be dismissed outof hand.

While many of the health care disciplinesmake valuable contributions to the treatmentof addictive disorders, and while the AddictionMedicine physician is a member of a largertreatment team made up mostly of non-physicians, ASAM is the only organizationthat has as its primary focus the educationof doctors of all specialties about addiction.

No other organization in the U.S. wasfounded for this purpose. If ASAM does notdedicate 100% of its resources to the educa-tion of physicians, it is failing in its mission.To dedicate even one iota of an ASAMmember’s time and energy, or one iota of anASAM staff member’s time and energy, orone dollar of the ASAM budget to therecruitment and education of non-physiciansis to divert those resources from servingASAM’s mission to educate physicians.

Should Non-Physicians Be Admitted to Membership in ASAM?The Case AGAINST Associate Membership

James F. Callahan, D.P.A.Former ASAM Executive Vice President

Can ASAM turn over to ABAM the task ofachieving ABMS recognition? In April 2007,the ASAM Board of Directors did what noother ASAM Board had been able to achieve;it passed an historic resolution: That ASAMencourage and assist in the development ofthe American Board of Addiction Medicine(ABAM) and its application for recognitionof ABAM by the American Board of MedicalSpecialties (ABMS)….

Rather than divert resources to recruit non-physician members, all the energies thatASAM can muster and all the energies thatABAM and The ABAM Foundation can mustermust be focused on the recruitment, educa-tion and certification of physicians in theseeight specialties (many of whom practiceAddiction Medicine, but are not ASAMmembers), and on meeting the requirementsfor recognition of Addiction Medicine by theAmerican Board of Medical Specialties (ABMS),especially the requirement to develop accred-ited training programs in Addiction Medicinefor physicians from all specialties who wishto be trained.

We have to keep front and center the factthat the ASAM members’ number one prior-ity is ABMS Board certification for AddictionMedicine. The 2003 Member Survey reported“board certification” as the number oneinterest. The survey report says, It is clear thatmembers should pursue one major initiativein the future: advancing the specialty bygaining ASAM’s “board certified” status onaddiction medicine. A variety of otherpotential new initiatives…are supported byabout two-thirds of ASAM’s members butnone of these potential program-service-benefits have the same degree of membersupport found for gaining “board certified”status for the addiction medicine specialtyin the short-term.(81% selected this as the major initiative)(Suvey, p.13).

Would non-physician members be an assetgain, or would they create new costs?While the ASAM Membership Committeemay make the non-physician membership

recommendation as a means of strengthen-ing ASAM, I believe that allowing non-physi-cian members will weaken the Society anddrain resources from ASAM’s mission.Some may argue that non-physician member-ship dues and other payments will financiallystrengthen ASAM. In fact, having non-physician members will bring additional costsand service demands. To name only a fewsuch demands, non-physician members willwant to (1) have time allocated for workshopsand symposia at the Annual Medical Scientificconference (and other conferences), in orderto address issues pertinent to non-physicianmembers (but which may not be pertinentto physician members), (2) have space in theASAM News (and other publications) and theWebsite, in order to represent and discussissues pertinent to non-physicians (but whichmay not be pertinent to physicians), and (3)have ASAM represent their concerns (whichmay not coincide with physician memberconcerns) in state legislatures, at Congres-sional Committee hearings, with third-partypayers and others.

Does ASAM have sufficient staff and moneyto recruit and support non-physician members?If non-physician members are viewed as anasset to the Society, then they should berecruited with vigor. This means that theASAM staff must design recruiting materialstargeted to the non-physician audiences, andthose materials must speak to the needs ofthe several types of potential non-physicianmembers.

If ASAM invites non-physician members tojoin the Society, then ASAM is also invitingthe non-physician members to bring theirprofessional desires and concerns with them,so that these concerns may be aired andaddressed within the halls of the Society.

The ASAM staff cannot currently giveadequate support to the important requestsof ASAM members who want to organize andadminister their state Chapters. It is hard toimagine that ASAM will have the staff andthe money to recruit and service the concernsof non-physician members.

The question of Associate Membership will be discussed at a special Membership Forumduring Med-Sci, scheduled for Sunday morning, May 3rd, from 8:00 to 10:00 a.m.

All Med-Sci registrants are invited to join this important discussion.


RUTH FOX MEMORIAL ENDOWMENT FUND

Dr. Ruth Fox

Max A. Schneider, M.D., FASAM Claire OsmanChair, Ruth Fox Memorial Endowment Subcommittee Director of Development

Dear Colleague:The 2009 Ruth Fox Donor Reception is scheduled for 6:30 to 8:30 p.m.

on Friday evening, May 1st, during ASAM’s Medical-Scientific Conferencein New Orleans. The reception honors the generosity of those who havemade donations to the Fund. As in years past, the cost of the receptionhas been underwritten by a generous gift from ASAM members Dr.Tommie F. Lauer and Dr. Joseph E. Dorsey and Mrs. Dorsey. We thankthem for their generosity in making the evening possible.

The Reception provides an opportunity to celebrate the achievementsof this year’s recipients of the Ruth Fox Scholarships, given to an out-standing group of physicians-in-training. To date, 28 such scholarshipshave been awarded. Scholarships cover travel, hotel and registration

expenses for recipients to attend ASAM’s Annual Medical-Scientific Conference and Ruth FoxCourse, as well as one year’s free membership in ASAM. The four scholarship recipients for 2009 are:

� Bethany C. Arber Calkins, M.D., Rochester, New York (Family Medicine — University of Roches-ter Medical Center)

� James Fausto, M.D., New York City (Family Medicine — Albert Einstein College of Medicine/Montefiore Medical Center)

� Jennifer J. Nadeau, M.D., San Diego, California (Psychiatry — Univerity of California San Diego)

� Sam Schwendiman, M.D., Clawson, Michigan (Addiction Psychiatry — Henry Ford Hospital/Case Western Reserve University)

Invitations to the Ruth Fox Donor Reception are extended only to donors, so if you have notalready contributed or pledged to the Endowment Fund, please do so now. For informationabout making a pledge, contribution, bequest, memorial tribute, or to discuss other types ofgifts in confidence, please contact Claire Osman by phone at 1-800/257-6776 or 1-718/275-7766,or email Claire at [email protected]. She welcomes your calls. All contributions to theEndowment Fund are tax-deductible to the full extent allowed by law.

ASAM STAFF & CONSULTANTSEileen McGrath, J.D.Executive Vice President/[email protected]

Nancy BrighindiDirector of Membership& Chapter [email protected]

Jennifer BrownellConsultant, StrategicPartnerships & [email protected]

Gionne Graetz CelebiManager, Strategic Partnerships& Product Developmentand [email protected]

Ruby Bailey EdmondsonOffice Manager/[email protected]

Valerie FooteData Entry [email protected]

Except where indicated, all staff can be reached at ASAM’s Headquarters Office,4601 North Park Ave., Suite 101 Upper, Chevy Chase, MD 20814; phone 301/656-3920; [email protected].

Joanne [email protected]

Tracy Vilella GartenmannDirector, Strategic Partnerships& Product Development (SPPD)and [email protected]

Alexis Geier-HoranDirector, Government [email protected]

Amy HotalingMember & ChapterDevelopment [email protected]

Sandra MetcalfeCME [email protected]

Claire OsmanDirector of DevelopmentPhone: 1-800/257-6776Fax: 718/[email protected]

Laura Kay-RothExecutive Assistantto the EVP/[email protected]

Noushin ShariateAccounts [email protected]

Leslie StraussExhibits Manager, [email protected]

Angela WarnerSenior Consultant, StrategicPartnerships & [email protected]

Lisa Watson, CMPDirector, Meetingsand [email protected]

Christopher WeirsDirector of Credentialing/IT [email protected]

Darlene WilliamsPain & Addiction ProgramManager and SPPD [email protected]

Bonnie B. WilfordEditor, ASAM News210 Marlboro Ave.Suite 31, PMB 187Easton, MD 21601Phone: 410/770-4866Fax: 410/[email protected]

MAINE –PORTLAND AREA

Join unique programseeking a BC FamilyPhysician or Internist

dedicated to full-spectrumaddiction treatment.

Superb team of physicians and supportprofessionals committed to

individualized recovery. Programincludes partial hospitalization,outpatient, and inpatient care.

Competitive income, generousrelocation, full benefits. 39 days

combined vacation/CME. Educationalloan repayment. Suboxone Certification

required before start date.

Portland offers a lively waterfrontmetro environment with easy access

to outdoor recreation, art andperformance venues.

CONTACT: Lianne Harris,New England Health Search

PHONE: [email protected]

MAIL TO: [email protected]

Med-Sci 2009 15

ASAM’s 40th Annual Medical-Scientific Conference honorsthe memory of three outstanding leaders in the field.

IN MEMORIAM

IN MEMORIAM:LECLAIR BISSELL, M.D.

IN MEMORIAM:MARTY DOOT, M.D.

IN MEMORIAM:RON DAVIS, M.D.

L ECLAIR BISSELL, M.D., aninternationally known and

much-published expert on addic-tion, died August 20, 2008, inSanibel, Florida. She was 80.

Dr. Bissell and her life partner of48 years, Nancy Palmer, moved toFlorida in 1968, buying one of theoldest homes in Sanibel. Aftersharing the home for more than 40years, the couple donated it to theSanibel Historical Village, where itis now open for tours. Ms. Palmerdied in 2007 after a long battlewith Alzheimer’s disease.

An outspoken champion ofwomen’s rights, the DemocraticParty, animal rescue groups andmany other causes, Dr. Bissell’sopinions often appeared in localand national newspapers. However,many readers did not know she wasa pioneer in addiction research.Awards for her professional contri-butions included the ASAM AnnualAward in 2000 and the ElizabethBlackwell Award for outstandingcontributions to the cause of womenand medicine in 1997. In 2007, shewas honored by the Florida Com-mission on the Status of Women forher life’s work.

Dr. Bissell’s work also was knowninternationally. Long-time friendSteve Mullins, M.D., reported thathe’d heard from dozens of doctorsaround the world who learned ofDr. Bissell’s death with real sorrowand shock. Noting that “No onecould have been more honest,straightforward, and sincere thanLeClair,” Dr. Mullins described Dr.Bissell as “a pioneer in the humanemanagement of alcoholism anddrug addiction. . . [who] was deeplyloved by many medical personnelwhom she helped overcome addic-tion over the years.”

R ONALD DAVIS, M.D., aged 52, passedaway November 6, 2008, after a coura-

geous 10-month battle with pancreatic cancer.A graduate of the University of Chicago

medical school, Dr. Davis trained at the U.S.Centers for Disease Control and Prevention(CDC) as a field epidemiologist and a preven-tive medicine resident. He went on to serveas the first director of the Office on Smokingand Health (OSH), where he worked withSurgeon General C. Everett Koop, M.D., onthree landmark reports: Nicotine Addiction,25 Years of Progress, and Smoking Cessation.Subsequently, he was the chief medical officerfor the Michigan Department of Public Healthuntil assuming his most recent position asDirector of the Center for Health Promotionand Disease Prevention for the Henry FordHealth System in Detroit, Michigan.

Dr. Davis reached the pinnacle of Americanmedicine at a relative young age when hewas elected the 162nd President of theAmerican Medical Association in June 2007– the first preventive medicine specialist everto serve in that post. On behalf of the AMA,he advocated for improved access to healthcare and the importance of prevention andsound public policy.

A gifted educator, Dr. Davis gave countlesslectures and educational seminars. He also wasa prolific writer and the founder of TobaccoControl: An International Journal, which heserved as editor between 1992 and 1998.

Dr. Davis’ career-long fight against alcohol,tobacco and other drugs was recognizedwith numerous awards and honors. However,his legacy is much deeper. In a movingspeech to the AMA House of Delegates inJune 2008 (which can be accessed at HTTP://WWW.AMA-ASSN.ORG/AMA/PUB/CATEGORY/18670.HTML), Dr. Davis offered hope to thosewith cancer, and urged his audience to takethe time to remember to love those aroundthem. As one of his many friends noted,“Ron’s legacy is the example he set for all ofus…through the strength of his character,impeccable integrity, graciousness and style,and his dedication to serve his fellow man.”

MARTIN (MARTY) DOOT, M.D., FAAPP,FASAM, passed away suddenly on Novem-

ber 14, 2008, at age 60.At the time of his death, Dr. Doot was chief

of addiction medicine at Lutheran GeneralHospital and associate medical director ofAdvocate Medical Group in Park Ridge, Illinois,where he was responsible for clinical informaticsand directed the Advocate Addiction TreatmentProgram. He also served as director of the IllinoisProfessional Health Program.

Before joining Advocate, Dr. Doot was directorof medical education for Parkside at LutheranGeneral Hospital and served as vice presidentof medical services with Lutheran GeneralBehavioral Health. Before joining Lutheran Gen-eral in 1984, he worked at McNeal MemorialHospital in Berwyn, Illinois, as medical directorof the alcohol treatment program and assistantdirector of family practice.

A Fellow of the American Society of Addic-tion Medicine and the American Academy ofFamily Physicians, Dr. Doot published numerousarticles and book chapters on addiction topicsand the practice of addiction medicine. He alsowas an early and articulate advocate foremploying therapeutic rather than punitiveinterventions with physicians and other healthcare professionals who were impaired by alcoholor other drug use, and was a frequent advisorto the American Medical Association as it workedto build the first national network of state Phy-sician Health Programs.

John Sage, M.D., medical staff president atLutheran General, observed that “Marty (leaves)a legacy as friend, educator, and thought leaderfor our community. [His] compassionate andwhole-patient approach to addiction treatmentdefined the addiction programs at AMG andLutheran General, and attracted the attentionof peers, clinicians, social workers and patientsfrom around the globe. Indeed, just days beforehis passing, Dr. Doot hosted a delegation ofaddiction treatment providers from Minsk,Belarus.” And just a week earlier, he shared hisknowledge with other addiction medicinespecialists as a lecturer at a course sponsoredby the Illinois Society of Addiction Medicine.

ASAM CONFERENCE CALENDAR

April 30, 2009Ruth Fox Course for PhysiciansNew Orleans, Louisiana[8 Category 1 CME Credits]

April 30, 2009Pain and Addiction:Common Threads X –New Orleans, Louisiana[8 Category 1 CME Credits]

April 30-May 3, 200940th Annual Medical-Scientific ConferenceNew Orleans, Louisiana[22.5 Category 1 CME Credits]

October 22–24, 2009ASAM Course on theState of the Art inAddiction MedicineHyatt Regency Capitol HillHotel, Washington, DC[21 Category 1 CME Credits]

OTHER EVENTS OF NOTE

Except where otherwise indicated, additional information is availableon the ASAM website (WWW.ASAM.ORG) or from the ASAMDepartment of Meetings and Conferences at 4601 No. Park Ave.,Suite 101, Chevy Chase, MD 20815-4520; phone 301/656-3920; fax301/656-3815; email [email protected].

May 7-8, 2009Prescribing Opioids for Chronic PainSponsored by the Illinois Societyof Addiction Medicine, Illinois Dept.of Alcohol and Substance Abuse,and Illinois State Medical SocietyMay 7th at the Abraham LincolnHotel, Springfield, IL;May 8th at the Westin O’HareHotel, Chicago, IL5 Category I CME creditsFor more information or to register,visit HTTP://ILSOCIETYOFADDICTIONMEDICINE.ORG/CONFERENCE.HTM

May 14, 2009Prescribing Opioids for Chronic PainSponsored by the New YorkAcademy of Family PhysiciansRochester, New York4 Category I CME creditsFor more information or to register,visit HTTP://WWW.NYSAFP.ORG

May 15, 2009Prescribing Opioids for Chronic PainSponsored by AOAAMHyatt Regency Dearborn HotelDearborn, Michigan4 Category 1 CME creditsFor more information or to register,email [email protected]

ASAM EVENTS SPECIAL SESSIONS OPEN ASAM MEETINGThe following social and educational events on Thursday evening, April30th, kick off ASAM’s Annual Medical-Scientific Conference in New Orleans:

Thursday, 5:00 - 6:00 p.m.New Members’ Welcome ReceptionSponsored by Loma Linda Univ. Behavioral Medicine Center, Redlands, CA

6:00 - 8:00 p.m.Welcoming Reception and Opening of ASAM Exhibit HallSponsored by the Louisiana Chapter of ASAM

7:00 - 9:00 p.m.Chapters Council MeetingIn addition to the general meeting, individual chapters will meet through-out the Med-Sci Conference. See the ASAM Registration Desk for a schedule.

8:00 - 10:00 pmComponent Session I: AA in Vivo — Workshop in the Twelve-StepRecovery Action GroupChair: Marc Galanter, M.D., FASAMSpeakers: Marc Galanter, M.D., FASAM; Penelope Ziegler, M.D.;Richard K. Ries, M.D.

Component Session II: Update on the ASAM Patient Placement CriteriaChair: Marc J. Fishman M.D.Speakers: David Mee-Lee M.D.; George Kolodner, M.D.

Component Session III: Moving Addiction Medicine into Family MedicineChair: Norman Wetterau, M.D., FAAFP, FASAMSpeakers: Richard Blondell, M.D.; Anthony Cloy, M.D.; Gerald Shulman, M.A.

Component Session IV: Opioid Agonist Treatment —Training, Clinical Practice and Policy InitiativesChair: Daniel P. Alford, M.D., M.P.H., FACPSpeakers: Andrew J. Saxon, M.D., Edwin Salsitz, M.D., FASAM;Adam J. Gordon, M.D., M.P.H., FASAM; Daniel Alford, M.D., M.P.H., FACP;Laura F. McNicholas, M.D., Ph.D.; John A. Renner, Jr., M.D., DFAPA

Component Session V: Public Policy in Addiction Medicine:Past, Present, and FutureCo-Chairs: Petros Levounis, MD, MA and Mark L. Kraus, MD, FASAMSpeakers: Mark L. Kraus, M.D., FASAM; Petros Levounis, M.D., M.A.;David E. Smith, M.D., FASAM; Louis E. Baxter, Sr., M.D., FASAM

Phone 1.800.844.8948 or visit the ASAM Exhibit Booth to order your copy today!

”

“Detailed, practical, and clearlywritten…truly comprehensivein its coverage…an essentialresource…Journal of the American MedicalAssociation

This is the guide to the scienceand practice of AddictionMedicine!Michael M. Miller, M.D., FASAMMedical Director, Meriter Hospital

This innovative reference is offeredfor a limited time at a special priceof $39.95 to ASAM members and$49.95 to non-members.

on CD-Rom!

NEW!

• The entire Third Edition of ASAM’sessential textbook on one CD —all 1644 pages on a single disk.

• Fully searchable — find the informationyou need when you need it.

• User-friendly — an ideal companionto the print text.

Med-Sci 2009

Documents

Transcript of Med-Sci 2009